B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 0.644 EUR 7.33% Market Closed
Market Cap: 19.8m EUR

Wall Street
Price Targets

BRETEC Price Targets Summary
Bioretec Oy

Wall Street analysts forecast BRETEC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRETEC is 0.612 EUR with a low forecast of 0.606 EUR and a high forecast of 0.63 EUR.

Lowest
Price Target
0.606 EUR
6% Downside
Average
Price Target
0.612 EUR
5% Downside
Highest
Price Target
0.63 EUR
2% Downside
Bioretec Oy Competitors:
Price Targets
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
47% Upside
EW
Edwards Lifesciences Corp
14% Upside
7716
Nakanishi Inc
31% Upside
CYRX
Cryoport Inc
41% Upside
NVCR
Novocure Ltd
93% Upside
EMBLA
Embla Medical hf
14% Upside
STMN
Straumann Holding AG
23% Upside
NRXS
Neuraxis Inc
34% Upside

Revenue
Forecast

Revenue Estimate
Bioretec Oy

For the last 5 years the compound annual growth rate for Bioretec Oy's revenue is 21%. The projected CAGR for the next 3 years is 31%.

21%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRETEC's stock price target?
Price Target
0.612 EUR

According to Wall Street analysts, the average 1-year price target for BRETEC is 0.612 EUR with a low forecast of 0.606 EUR and a high forecast of 0.63 EUR.

What is Bioretec Oy's Revenue forecast?
Projected CAGR
31%

For the last 5 years the compound annual growth rate for Bioretec Oy's revenue is 21%. The projected CAGR for the next 3 years is 31%.

Back to Top